U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07210320) titled 'PK/PD Study of IN-001 Sublingual Spray in Healthy Adults' on Sept. 29.
Brief Summary: This is an open-label, two-part study to assess the pharmacokinetics (PK) and pharmacodynamics (PD) of epinephrine administered as a single dose of L-dipivefrin (IN-001) sublingual spray in healthy adults. For both parts of the study, participants will undergo at least 10 hours of fasting prior to dosing. Part 1 of the study focuses on IN-001 dose/formulation exploration in a small number of participants (N=6) to help select the most appropriate dose/formulation to be used in Part 2 of the study in a larger number of participants (N=24).
Study Star...